Related Experiment Video
Updated: Nov 6, 2025
05:34
Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP
Published on: September 8, 2023
1.0K
Sensitive on-site detection of SARS-CoV-2 by ID NOW COVID-19
Eva Krause1, Andreas Puyskens1, Daniel Bourquain1
1Centre for Biological Threats and Special Pathogens - Highly Pathogenic Viruses (ZBS 1), Robert Koch Institute, Seestraße 10, 13353 Berlin, Germany.
Molecular and Cellular Probes
|May 10, 2021
Abstract:
Point of care detection of SARS-CoV-2 is one pillar in a containment strategy and important to break infection chains. Here we report the sensitive, specific and robust detection of SARS-CoV-2 and respective variants of concern by the ID NOW COVID-19 device.
